What is the expected outcome for an 84-year-old woman with a history of atrial fibrillation (AFib), heart failure with preserved ejection fraction (HFpEF), and acute on chronic kidney disease with impaired renal function, recently hospitalized for shortness of breath and palpitations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 22, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Prognosis for 84-Year-Old Woman with AFib, HFpEF, and Acute on Chronic Kidney Disease

The expected outcome for this 84-year-old woman with multiple comorbidities is poor, with high risk of mortality within 6-12 months and further deterioration of renal function due to the cardiorenal syndrome. 1, 2

Risk Assessment

Negative Prognostic Factors Present:

  • Advanced age (84 years): Age is an independent predictor of poor outcomes in both heart failure and kidney disease 2
  • Multiple comorbidities:
    • Atrial fibrillation
    • Heart failure with preserved ejection fraction (HFpEF)
    • Acute on chronic kidney disease
    • Severely impaired renal function (creatinine 3.8, low GFR)
  • Recent hospitalization: Recent admission for cardiopulmonary symptoms indicates disease progression
  • Cardiorenal syndrome: The bidirectional relationship between heart and kidney dysfunction significantly worsens prognosis 3

Specific Mortality Risk Factors:

  1. Female gender: Independent predictor of post-discharge mortality in AKI survivors 2
  2. High comorbidity burden: The Charlson Comorbidity Index would be elevated given her multiple conditions 2
  3. Acute decompensation: Recent hospitalization for shortness of breath and palpitations suggests acute decompensation 4
  4. Severe renal dysfunction: Creatinine of 3.8 indicates severe kidney impairment 2
  5. AFib with HFpEF: This combination is associated with higher 12-month mortality compared to HFpEF alone 5

Expected Clinical Course

Short-term (1-3 months):

  • High risk of rehospitalization (>50% at 6 months) 4
  • Continued symptoms of exercise intolerance, dyspnea, and fatigue 6
  • Likely further deterioration of renal function 7

Medium-term (6-12 months):

  • Approximately 30% one-year mortality risk based on heart failure hospitalization data 4
  • Progressive worsening of cardiorenal syndrome 8
  • Increasing burden of symptoms affecting quality of life 6

Specific Complications to Anticipate

  1. Worsening renal function:

    • Further decline in GFR
    • Potential need for renal replacement therapy if progressive uremia and volume overload develop 1
    • Limited ability to use renin-angiotensin-aldosterone system blockers 1
  2. Heart failure progression:

    • Recurrent episodes of decompensation and congestion 6
    • Worsening cardiac mechanics due to cardiorenal syndrome 7
    • Increased left ventricular filling pressures 9
  3. Atrial fibrillation complications:

    • Increased thromboembolic risk
    • Contribution to further heart failure exacerbations 5
    • Limited rhythm control options due to renal dysfunction

Management Considerations

Medication Challenges:

  • GDMT limitations: Many guideline-directed medical therapies will be limited by renal dysfunction 1
  • Diuretic management: Careful balance needed between treating congestion and avoiding further renal injury 3
  • Anticoagulation: Necessary for AFib but complicated by renal dysfunction and fall risk

Volume Management:

  • Diligent management of volume status is critical but challenging with concurrent renal dysfunction 1
  • Careful monitoring for signs of congestion versus dehydration

Multidisciplinary Approach:

  • Nephrology consultation for co-management of cardiorenal syndrome 1
  • Consider palliative care involvement given poor prognosis

Pitfalls to Avoid

  1. Overdiuresis: Can worsen renal function and cause hypotension
  2. Undertreatment of congestion: Fear of worsening renal function should not prevent appropriate diuresis when needed
  3. Medication toxicity: Many medications require dose adjustment or avoidance with severe renal dysfunction
  4. Ignoring quality of life: Focus should include symptom management, not just survival
  5. Delayed goals of care discussions: Given poor prognosis, advance care planning is essential

In summary, this patient faces a guarded prognosis with high risk of mortality and progressive functional decline due to the complex interplay between her cardiac and renal conditions, advanced age, and recent decompensation.

References

Research

Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.

Clinical research in cardiology : official journal of the German Cardiac Society, 2024

Related Questions

Should any further adjustments be made to the treatment of an 84‑year‑old man with chronic heart failure with preserved ejection fraction (NYHA class III), atrial fibrillation on reduced‑dose apixaban, recent acute respiratory infection treated with amoxicillin‑clavulanate, chronic kidney disease (eGFR ≈ 35‑40 mL/min), anemia, elevated C‑reactive protein, and markedly increased NT‑proBNP?
What anesthesia restrictions apply to a patient with controlled diastolic heart failure (heart failure with preserved ejection fraction)?
What is the appropriate assessment and management plan for an 89‑year‑old woman with chronic bilateral lower‑extremity lymphedema, heart failure with mid‑range ejection fraction, atrial fibrillation (Watchman device), tachy‑brady syndrome with pacemaker, type 2 diabetes, chronic kidney disease, presenting with progressive leg aching and edema after stopping compression therapy, polyuria, recent urinary tract infection treated with antibiotics, mild orthopnea, occasional orthostatic light‑headedness, right ankle sprain, mild leukocytosis, hyperkalemia, metabolic acidosis with elevated anion gap, baseline creatinine, elevated B‑type natriuretic peptide, rising troponin, and urinalysis showing glucosuria, mild proteinuria and hematuria?
In a patient with heart failure with preserved ejection fraction on torsemide 20 mg every other day for fluid overload and with stable impaired renal function, should any further medication adjustments be made?
What is a normal ejection fraction and what ejection fraction values are considered pathologic?
Can steroids help manage an acute gout flare?
What are the potential long-term psychological effects on an adult who learned to suppress emotions as a child due to a traumatic upbringing with exposure to domestic violence, parental mental health issues, and untreated emotional trauma?
Should a dental implant procedure be postponed in a patient with an acute cough?
What is the recommended dose and duration of prednisolone (corticosteroid) for the treatment of croup in children?
What is the treatment for issues related to the gastric cardio-oxyntic mucosa, such as gastritis or ulcers?
What is the next best medication for a patient with treatment-resistant depression and social anxiety, currently on fluoxetine (Prozac)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.